ONLY AVAILABLE ON LINE 
Program Sessions (On demand)
On demand  The role of associations as industry growth drivers: achivements & future strategies
(more info)
Moderator: Ion Arocena. Managing Director. AseBio (Spain)

Joseph Damond. Deputy Chief of Policy & Executive VP, International Affairs. BIO (USA)
Claire Skentelbery.
Director General. EuropaBio (Belgium)
Vicki L. Loise.
CEO. SLAS (USA)

On demand Hospitals dynamizing the biotech industry
(more info)
Moderator: Diego Velasco. Head of Innovation. Ramon y Cajal Research Institute (Spain)

Diego Velasco. Head of Innovation. Ramon y Cajal Research Institute (Spain)
Lluís Blanch. Head of Research and Innovation. Corporació Sanitària Parc Taulí (Spain)
Ion Arocena. Managing Director. AseBio (Spain)
Felipe Prosper. Head of the Cellular Therapy Unit and Co-director of the Haematology and Haemotherapy Unit at the Clínica Universidad de Navarra. Clinica Universitaria de Navarra (Spain)
Alfredo Martínez Larrea. Managing Director. Complejo Hospitalario de Navarra (CHN). (Spain)

On demand Focus on spain: biotech clusters and regional strategies
Moderator: Izaskun Goñi. Directora general de Política de Empresa, Proyección Internacional y Trabajo (Spain)

Melqui Calzado. Secretary General. CataloniaBIO & HealthTech (Spain)
Loli Pereiro.
Cluster Manager. BIOGA (Spain)
María Pascual de Zulueta.
Managing Director. Basque Health Cluster (Spain)

On demand Navarra, 20 años apostando por el sector salud
Moderator: Pilar Irigoien. Directora Gerente. SODENA (Spain)

Francisco José Aranda Campos. Market Access & Quality Corporate Director, CINFA GROUP (Spain)
Carlos Yañez.
Socio, GEISER PHARMA (Spain)
Ángel Ursua.
Director Técnico IDIFARMA (Spain)

On demand  Company presentations
ADL BIOPHARMA
ADNTRO GENETICS
AIN-ASOCIACIÓN DE LA INDUSTRIA NAVARRA
ALGAENERGY
ALLADVICE REGULATORY CONSULTANTS
ÄMSBIOPHARMA
ASPHALION
AZUR GLOBAL NUTRITION
BIOMÉRIEUX
BIOREPOS
BIOTECNOFE
CELLAB
CELTARYS
CENER BIO2C
CLAVE MAYORCOOL CHAIN LOGISTICS
DIVERSA TECHNOLOGIES
ENFORCED LABORATORY UNIVERSAL
FLOMICS BIOTECH
FUNDACIÓN MEDINA
GALARIA
GATE2BRAIN, S.L.
INHIBITEC ANTICUERPOS, S.L.
IQS
ISERN PATENTES Y MARCAS
MICHROMA
NATUREMIMETIX
NOWTURE SL
NUCAPS NANOTECHNOLOGY, S.L.
NUTRICIÓN 3G
PROTOQSAR 2000
VIVEBIOTECH
ZECLINICS
On demand  Academic/Business plan company presentations
ACADEMIC PRESENTATIONS
FLOMICS BIOTECH
HYPERBOLA CLOUD
KEY BIOLOGICAL
BUSINESS PLAN COMPANY PRESENTATIONS
ABILITY PHARMACEUTICALS, SL
AINIA
ARTHEX BIOTECH S.L.
BFLOW
CRAZY SCIENCE AND BUSINESS
INCLIVA
INHIBITEC ANTICUERPOS
INNOUP FARMA
LENTISTEM BIOTECH
LIMNOPHARMA
LINKNOVATE
NEUROFIX
PULEXLAB
VAXDYN
On demand Clusters/Country Presentations
ARGENTINA
ASTUREX
BASQUE HEALTH CLUSTER
BIOGA
BIOPARTNER UK
BIOVAL
CASTILLA Y LEON
INNOVMEDICA POLEURO
INVEST IN SPAIN
ONLY AVAILABLE ON LINE
09:00-18:00 VIRTUAL EXHIBITION
09:00-00:00 VIRTUAL PARTNERING
Program Sessions
11:30-12:30 SESSION
Cell Therapy Manufacturing Trends and Drivers for Success

(more info)
Antoine Heron. Cell Therapy Bioprocessing Group. Gene Editing and Novel Modalities. Merck Life Science (France)
16:00-17:00 SESSION
Genome Project-write: An international collaboration project
(more info)
Moderator: Juanjo Rubio. Navarre’s Social Innovation Unit (Spain)

George Church. Ph.D. Founding Core Faculty Members Wyss Institute at Harvard University.(U.S.A.)
Andrew Hessel. Chairman of the Board and Co-Executive Director, Genome Project-write. (U.S.A.)
Amy Cayne Schwartz, J.D. President and Co-Executive Director, Genome Project-write. (U.S.A.)

 

ONLY AVAILABLE ON LINE
09:00-17:30 VIRTUAL EXHIBITION
09:00-00:00 VIRTUAL PARTNERING
Program Sessions (streaming)
10:00-11:00 SESSION
Talent attraction  BANDERA ESPAÑOLA ESPAÑA 90X60 CM ADAPTADA PARA MASTIL CON ESCUDO PALO SPAIN | eBay
(more info)
Moderator: Tomás Alarcón. Human Resources Director, 3P Biopharmaceuticals. (Spain)

Elena Rivas. CEO / Vice-President of the Spanish Biotechnological Companies Association – AseBio (Spain)
Oscar Porcel
. Managing Partner, Solutia Global Health Solutions (Spain)
Juan Diego Casas. Partner & Head of Life Sciences, Talengo (Spain)
Eva Ortega-Paíno. Secretary General, Raicex (Spain)

11:30-12:45 SESSION
How gender diversity can improve Biomedicine
(more info)
Moderator: Simón Perera. General Secretary. PRISMA (Spain)

María José Rementería. Social Link Tics Team Leader. Barcelona Supercomputing Center (Spain)
Eva Pérez Nanclares.
Legal Advisor / exVicePresident. GSK / REDI (Spain)
Juan Cruz Cigudosa.
Counselor of University, Innovation and Digital Transformation of Navarra. Government of Navarra (Spain)
Deborah Burks.
Director. Príncipe Felipe Research Center (Spain)
Paula Olazabal. Partner – Diversity & Inclusion Manager. Ysios Capital (Spain)

13:00-13:30 SESSION                                                                                                                                                                                    
Patient centricity in clinical trials: challenges and lessons learned
   
(more info)
Gonzalo Peral. Business Development Manager, World Courier Spain (Spain)
20:30-22:30 Investors & Sponsors Reception
AVAILABLE ON LINE & ON SITE
(confirmation through the registration form is compulsory)
09:00-18:00 VIRTUAL EXHIBITION
09:00-00:00 VIRTUAL PARTNERING

Track 1: Health
Main Auditorium

 

Track 2: Agro-Food-Bioeconomy
Camara Auditorium

09:00-10:15 SESSION
Are we ready for the next pandemic?
(more info)
09:00-09:30 SESSION
PRESENTACIÓN DEL PROYECTO COMPITTE
Madrid Norte – Fundacion Universidad Autónoma de Madrid

Anticipating future scenarios

Moderator: María Isabel Rodrigo. Deputy Director for Outpatient Processes and Diagnosis. Navarra Hospital Complex (Spain)

Antonio Lopez Navas. Spain’s National Plan Against Antibiotic Resistance- PRAN AEMPS (Spain)
Katharina Hauck. Professor. Faculty of Medicine, School of Public Health. Imperial College (UK)

Biotech solutions for an effective response

Moderator: María Isabel Rodrigo. Deputy Director for Outpatient Processes and Diagnosis. Navarra Hospital Complex (Spain)

Alexander (Sandy) Douglas. Research Group Leader at the University of Oxford, UK
Juanjo Infante. CEO, Vaxdyn (Spain)
Dámaso Molero. CEO, 3P Bio (Spain)

Ana Méndez. Industrial and Intellectual Property. Fundación de la Universidad Autónoma de Madrid (FUAM) (Spain)
Carlos López. Innovation and Project Management. Fundación de la Universidad Autónoma de Madrid (FUAM) (Spain)
09:45-10:45 SESSION
Getting involved in the European Climate Change Pact

(more info)
Welcome message: ASEBIO
Moderator: María Segura Fornieles. Subdirectora General y Directora Técnica. AlgaEnergy (Spain)Enrique Espí Guzmán. Repsol Technology Lab (Spain)
Lorena Tudela Marco. Servicio de Estudios Agroalimentarios del Grupo Cooperativo Cajamar (Spain)
Javier Gil. Director Biomass Department. CENER (Spain)
Celsa Monrós Barahona. Director General of Climate Change. Ambiental Educators Association/Environmental Education Center of Valencia (CEACV), Regional Valencian Ministry of Agriculture, Natural Environment, Climatic Emergency and Ecological Transition (Spain)
Manuel Parga. Director of Marketing and Head of Sustainability of the Spanish Olympic Committee – Ambassador of the Climate Pact (Spain)
Katerina Fortun. DG “Climate Action” (CLIMA) / EC Representative (DG Clima), European Commission (Belgium)
10:15-11:15 SESSION
Vaccines: Covid-19 & Beyond

11:00-12:00 SESSION
Bioproducts: paving the way for a sustainable planet

(more info)
Moderator: José Escribano. CSO. ALGENEX – Alternative Gene Expression (Spain)

Mariano Esteban. Chief Researcher Poxvirus & Vaccines Group. National Biotechnology Center-CSIC (Spain)
Jerome Dalin. EMEA Core Modalities Strategy operationalization – Senior Consultant. Merck (Switzerland)
Arnaud Paris. Scientific Affairs Director, Pharmaceutical EMEA. BioMérieux (France)

Moderator: Inés del Campo. Senior R&D Engineer at the National Renewable Energy. CENER (Spain)

Begoña Ruiz. AINIA (Spain)
Michael Brandkamp. Managing Director. ECBF – European Circular Bioeconomy Fund (Germany)
Pilar Llorente Ruiz de Azua. Project Officer. BBI-JU (Belgium)
María Segura Fornieles. Subdirectora General y Directora Técnica. AlgaEnergy (Spain)

11:15-12:00 Institutional Welcome Remarks
Ana Polanco. President. AseBio – Spanish Bioindustry Association (Spain)
Xiana Méndez.
Secretary of State for Trade, Government of Spain
María Chivite.
Presidenta de la Comunidad Foral de Navarra (Spain)
12:00-12:30 BREAK
12:30-13:15 SESSION
Development and production of monoclonal antibodies 
(more info)
12:30-13:15 SESSION
Farm to fork: challenges & opportunities

(more info)
Moderator: Elena Erroba. Business Development Director, 3P Biopharmaceuticals (Spain)

Mark Wright. Head of Manufacturing, Nordic Nanovector (Norway)
Guillaume Plane. Biotechnology/Biomanufacturing expert, Merck Group (France)
Sabrina Cencig. Team Manager Bioprocess Specialist EMEA, Scientific and Laboratory Services (SLS). Pall Corporation (France)
Diego Bochoeyer. Director of Strategic Development and Supply Chain. 3P Biopharmaceuticals (Spain)

Moderator: César Marcos Cabañas. Coordinator & Communications Manager, ALAS / Reporter on El Economista (Spain)

María Segura Fornieles. Subdirectora General y Directora Técnica. AlgaEnergy (Spain)
Richard Borreani. Agricultural Policy & Stakeholders Affairs Manager, Bayer Crop Science Iberia
Gabriel Trenzado. Member of the Board of Directors. ALAS (Spain)

13:15-14:30 SESSION
Challenges of Preclinical Research in Spain BANDERA ESPAÑOLA ESPAÑA 90X60 CM ADAPTADA PARA MASTIL CON ESCUDO PALO SPAIN | eBay

(more info)
13:30-14:30 SESSION
Where do we stand on new genomic editing techniques?
(more info)
Moderator: Amelia Martín Uranga. Clinical and traslational research Associate Director. Farmaindustria (Spain)

Anabel Sanz. Head of Tech Transfer, CRG (Spain)
Jose Manuel Bartolomé. Scientific Director, Janssen (Spain)
Andrés Ubierna. Head of Department of Capitalisation of Technology Companies, CDTI (Spain)
Clara Campás. Managing Partner and Co-Founder. Asabys Partners (Spain)
Marisol Quintero. CEO, Highlight Therapeutics, (Spain)
Javier Granda. Health Journalist and Member of the Association of Health Informers (ANIS), (Spain)

Moderator: Gerardo Pisabarro. Professor of Genetics and Plant Breeding. Public University of Navarra (Spain)

Esperanza Orellana. Director General of Agricultural Productions and Markets. Ministerio de Agricultura, Pesca y Alimentación (Spain)
Clara Aguilera. Diputada en el Parlamento Europeo y Vicepresidenta de la Comisión de Agricultura y Desarrollo Rural, Parlamento Europeo . Parlamento Europeo (Belgium)
Petra Jorasch. Manager Plant Breeding Innovation Advocacy. Euroseeds (Belgium)

14:30-16:00 BREAK
16:00-17:00 SESSION
Innovations in high throughput screening platforms

(more info)
16:00-17:00 SESSION
The Future of Food: what we will be eating in 2030 thanks to biotechnology
(more info)
Moderator: Gijs J. Jochems. General Manager. Promega Biotech Ibérica S.L.Spain

Cell sensing: Dynamic film about cell feeling
Antonio Quilez. High Content Screening Manager at 4Cell  (Spain)
Zebrafish as an animal model for in vivo drug testing
Susana Pascoal. CSO. IKAN BIOTECH (Spain)
Illuminating Drug Discovery in Live Cells
María Jurado Pueyo. Application Specialist and Technical Support Manager. Promega Biotech Ibérica (Spain)
Shaping the future of Bioassays for drug discovery
José Julio Martín. Freelance. Sciengement Lab Consulting & SLAS European Ambassador (Spain)

Moderator: Bosco Emparanza. CEO. MOA Foodtech (Spain)

Goyo Sanzol. CEO. Pentabiol (Spain)
Inés Echevarría. Director of R&D. CNTA (Spain)
Mariano Oto. CEO. NUCAPS (Spain)
Javier Zaratiegui. CTO. CoCuus System Ibércia (Spain)
Sabas de Diego. CTO y Co-Fundador. Tebrio (Spain)

17:00-18:00 SESSION
Big Data & AI: : Re-shaping the Life Sciences sector

17:15-18:00 SESSION
Microbiome
(more info)
Moderator: Carlos López Molina. Professor. Department of Statistics, Informatics and Mathematics. Public University of Navarra (Spain)

Simón Perera. Business Development Manager. ProtoQSAR (Spain)
Ana Garcia Poyo. VP of Operations. Overture (Spain/USA)
Carolina Aguilar. Chief Executive Officer & Co-Founder. InBrain Neuroelectronics (Spain)
Nicola Richmond. Director Artificial Intelligence and Machine Learning. GlaxoSmithKline (United Kingdom)

Moderator: Daniel Ramon. CEO. ADM Biopolis (Spain)

Isabelle de Cremoux. CEO and Managing Partner. Targedys / Seventure Partners (France)
Fermín Milagro.
Director of the Nutriomics and Biomarkers. BIOTAGUT, Unav (Spain)
Pedro Gonzalez. CEO. Microomics (Spain)

19:00-20:00 Networking Event
Fronton Labrit (Calle Juan de Labrit, S/N)
20:00-00:00 Pintxo’s Route Downtown Pamplona

AVAILABLE ON LINE & ON SITE
(confirmation through the registration form is compulsory)

 

09:00-18:00 VIRTUAL EXHIBITION
09:00-00:00 VIRTUAL PARTNERING
Track 1: Health
Main Auditorium
Track 2: Finance-Investment
Camara Auditorium
09:00-09:45 SESSION
Paving the road from bech to bedside in ATMPs

(more info)
09:00-09:45 SESSION
Transforming knowledge into innovative solutions: the key role of VC

(more info)
Moderator: Lidia Canovas. General Manager, Regulatory Affairs. ASPHALION (Spain)

Mariano García. RedTerCel (Spain)
Darrin Morrissey. Chief Executive Officer. NIBRT (Ireland)
Sol Ruiz. Biological Products, Advanced Therapies and Biotechnology Division. AEMPS (Spain)
Pilar Redondo. Site Head. Takeda (Spain)

Moderator: Angel Peña. Journalist for Actualidad Económica, economic weekly of the daily El Mundo (Spain)

Luis Pareras. Managing Partner / Founder. Invivo Ventures / Healthequity (investor) (Spain)
Alain Huriez. Chairman and Managing Partner. Advent France (inversor internacional)
Clara Campas. Managing Partner & Co-Founder. Asabys Partners (inversor)
Gloria González-Aseguinolaza. Deputy Director. CIMA-Universidad de Navarra (Spain)

10:00-10:45 SESSION
Therapeutic adaptation to individualized patients needs: a collaborative approach for early adoption of new solutions

10:00-10:45 SESSION
Venture Capital

(more info)
Moderator: Patricia Fernandez Liz. Director Service Area – Galician Innovation Agency. Galician Innovation Agency – GAIN (Spain)

Desiree Teijeiro. COO. Libera Bio (Spain)
Juan Buela. Manager. Sunrock Biopharma (Spain)
Angela Perez. Vice President Life Sciences. Health in Code (Spain)

  Moderator: Alberto Sanz. Director of Financing & Investor Relations. ICEX-Invest in Spain (Spain)

Raúl Martín. Partner. Ysios Capital Partners (Spain)
Philippe Monteyne. Partner. Fund+ (Belgium)
Valerie Vanhooren. Co-Founder & CEO. Ona Therapeutics (Spain)
Hakan Goker. Managing Director. M-Ventures (Netherland)

   
10:45-11:15 SESSION
Hong Kong biomedical Cluster&Leading IPO center in Asia

(more info)
  Gregory Rall. Senior Manager Innovation & Technology. InvestHK Berlin (Germany)
Fernando de la Cal González. Deputy Head, Investment Promotion. InvestHK Brussels (Belgium)
11:00-11:45 SESSION
Main aspects to be considered for  gene therapies developement

(more info)
11:15-12:00 SESSION
IPO’s fueling the growth of biotech companies

Moderator: Gurutz Linazasoro. CEO. VIVEbiotech (Spain)

Massimo Dominici. Scientific Founder. Rigenerand (Italy)
Tol Trimborn. CEO. CellPoint (The Netherlands)
Natalia Elizalde. BD Director. VIVEbiotech (Spain)

Moderator: Susana de Antonio. Head of Listing Spain. Euronext (Spain)

Sara Secall. Inveready (Spain)
Carles Domenech.
CEO. Ability Pharmaceuticals (Spain)
Maite Malet.
Investment Associate. Asabys Partners (Spain)
Raul Insa.
CEO. SOM Biotech (Spain)

11:45-12:15 BREAK
12:15-13:00 SESSION
Time for HOPE? Precision Medicine in Modern Psychiatry and Neurodevelopmental disorders

(more info)
12:30-13:15 SESSION
Impulso del I+D+I a través de nuevos modelos innovadores de financiación BANDERA ESPAÑOLA ESPAÑA 90X60 CM ADAPTADA PARA MASTIL CON ESCUDO PALO SPAIN | eBay
Moderator: Tamara Maes. Co-Founder, VP of the Board of Directors and President of the Scientific Advisory Board of Oryzon Genomics (Spain)

Josep Antoni Ramos-Quiroga. Head of Department of Psychiatry. Department of Psychiatry. CIBERSAM. Hospital Universitari Vall d’Hebron, Barcelona (Spain)
Julian Nevado.
Responsable de Genómica Estructural y Funcional. INGEMM (Instituto de Genética Médica y Molecular). Hospital Universitario La Paz, Madrid (Spain)
Jaqueline Harris.
Assistant Professor of Neurology, Genetics, and Pediatrics. Kennedy Krieger Institute. Johns Hopkins Medical Institution (USA)
Angel Alonso.
Unidad de Medicina Genómica. Complejo Hospitalario de Navarra (Spain)

Moderator: Raquel Saiz. Directora de Análisis y Estrategia. AseBio (Spain)

Santiago Lozano. Tech Transfer Ventures Funds Manager. Clave (Spain)
Gustavo Pego. Managing Director Corporate Ventures. Universidad de Navarra (Spain)
Carolina Pola. Innovation Strategist. Kaudal (Spain)
Lluis Gomez. CEO. Draconis Pharma (Spain)

13:15-14:00 SESSION
Retos y oportunidades en el acceso y abordaje del cáncer BANDERA ESPAÑOLA ESPAÑA 90X60 CM ADAPTADA PARA MASTIL CON ESCUDO PALO SPAIN | eBay
13:15-14:00 SESSION
Gipuzkoa, growth path to become a world reference in advanced therapies
 
(more info)
Moderator: Marisa Garcia Vaquero. Directora de Market Access y Corporate Affairs. Merck España (Spain)

Jesús García Foncillas. Director de la cátedra Merck. UAM (Spain)
David Vicente. Director del Plan oncológico andaluz. Junta de Andalucía (Spain)
Ignacio Gil Bazo. Co-Director de Oncología de la CUN y Coordinador de la Línea estratégica (Oncología) de la Estrategia 2025 de la UNAV/CUN y CIMA. CIMA Universidad de Navarra (Spain)
Hugo Arasanz. Especialista en oncología médica – Servicio Navarro de Salud. Gobierno de Navarra (Spain)

Moderator: Angel Sánchez. Partner. SILO (Spain)

Iker Estensoro. Director of Economic Promotion. Provincial Council of Gipuzkoa (Spain)
Javier García-Cogorro. CEO. Viralgen (Spain)
Gurutz Linazasoro. CEO. VIVEbiotech (Spain)
Gloria González-Aseguinolaza. Deputy Director. CIMA-Universidad de Navarra (Spain)

14:00-15:30 BREAK
15:30-16:15 SESSION
Developing the next wave of diagnostic innovations: Gearing toward personalized medicine

(more info)
16:00-17:00 SESSION
Nextgen Funds  BANDERA ESPAÑOLA ESPAÑA 90X60 CM ADAPTADA PARA MASTIL CON ESCUDO PALO SPAIN | eBay
Moderator: Victor González. Director of R&D. Atrys (Spain)

Beatriz Maroto. Chief Operating Officer. AMADIX (Spain)
Esther Rodríguez. European Project Office Coodinator. ISCIII (Spain)
Felipe Prosper. Head of the Cellular Therapy Unit and Co-director of the Haematology and Haemotherapy Unit at the Clínica Universidad de Navarra. Clinica Universitaria Navarra (Spain)

  Moderator: Juan Luis Romera. Técnico/Asesor/Gestor en el Departamento de Promoción Institucional y Cooperación Territorial. CDTI (Spain)

Carlos Artal. Managing Director. Ayming (Spain)
José Alberto de la Parte. Manager of Strategic Projects. ZABALA (Spain)
Uxue Itoiz. General Director of Industry, Energy and Strategic Projects S3. Government of Navarra (Spain)

 

 
16:15-17:00 SESSION
Harnessing the opportunities of a new era in medicine: Personalized Medicine Strategies

(more info)
Moderator: Fina Lladós. General Manager. Amgen (Spain)

Juan Cruz Cigudosa. Consejero de Universidad, Innovación y Transformación Digital. Gobierno de Navarra (Spain)
Cristóbal Belda. Director. ISCIII (Spain)
Enrique de Álava. Professor and Chairman, Pathology, Institute of Biomedicine of Sevilla/Virgen del Rocío University Hospital (Spain)
Josep María Borrás. Director. Catalan Cancer Strategy (Spain)

   
17:00-18:00 SESSION
Partnership as a competitive strength: Immunotherapy & Oncology
17:00-18:00 SESSION
CRISPR: the next frontier in biotechnology
(more info)
 
 
Moderator: TBA

Julio Castro. CEO. Palobiofarma (Spain)
Marisol Quintero. CEO. Highlight Therapeutics SL (Spain)
Kathereh Ahmadi. Head of Search and Evaluation, European BD&L team. MSD (United Kingdom)

Moderator: Melqui Calzado. Secretary General. CataloniaBIO & HealthTech (Spain)

Javier Terriente. CEO, ZeClinics (Spain)
Graeme Garvey.
Head of Genome Engineering R&D, MilliporeSigma (USA)
Avencia Sanchez-Mejías.
CEO, Integra Therapeutics (Spain)

18:00-18:30 CLOSING REMARKS
 
 
 
Mikel Irujo. Regional Minister of Economic & Business Development, Government of Navarre
Diana Morant. Minister of Science & Innovation, Government of Spain

October 1st, Friday

ONLY AVAILABLE ON LINE
09:00-17:30 VIRTUAL EXHIBITION
09:00-00:00 VIRTUAL PARTNERING